Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Discovery to develop aerosolized formulations of Surfaxin

Feb. 28, 2000

New respiratory therapeutics from Zambon act as phosphodiesterase inhibitors

Feb. 28, 2000

PathoGenesis announces approval, distribution agreement for TOBI

Feb. 25, 2000

New treatment for COPD from Ono to enter clinical trials soon

Feb. 24, 2000

Life-saving treatment for pulmonary hypertension in newborn babies featured in NEJM

Feb. 23, 2000

Development of cystic fibrosis therapy advances at SciClone

Feb. 17, 2000

Antiallergic agents from SB act as CCR3 receptor antagonists

Feb. 16, 2000

Neurokinin antagonists in early development at AstraZeneca

Feb. 15, 2000

First market introduction for INOmax

Feb. 15, 2000

Synthesis and use of new PKC inhibitors in development at AstraZeneca

Feb. 15, 2000

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...